Literature DB >> 26490384

Establishing the Role of PPARβ/δ in Carcinogenesis.

Jeffrey M Peters1, Frank J Gonzalez2, Rolf Müller3.   

Abstract

The role of the nuclear hormone receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in carcinogenesis is controversial because conflicting studies indicate that it both inhibits and promotes tumorigenesis. In this review, we focus on recent studies on PPARβ/δ including the significance of increased or decreased PPARβ/δ expression in cancers; a range of opposing mechanisms describing how PPARβ/δ agonists, antagonists, and inverse agonists regulate tumorigenesis and/or whether there may be cell context-specific mechanisms; and whether activating or inhibiting PPARβ/δ is feasible for cancer chemoprevention and/or therapy. Research questions that need to be addressed are highlighted to establish whether PPARβ/δ can be effectively targeted for cancer chemoprevention.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; chemoprevention; mechanisms; peroxisome proliferator-activated receptor-β/δ; transcription factor

Mesh:

Substances:

Year:  2015        PMID: 26490384      PMCID: PMC4631629          DOI: 10.1016/j.tem.2015.09.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  84 in total

1.  The glucocorticoid receptor: rapid exchange with regulatory sites in living cells.

Authors:  J G McNally; W G Müller; D Walker; R Wolford; G L Hager
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

2.  PPARβ mRNA expression, reduced by n-3 PUFA diet in mammary tumor, controls breast cancer cell growth.

Authors:  Ramez Wannous; Emeline Bon; Karine Mahéo; Caroline Goupille; Julie Chamouton; Philippe Bougnoux; Sébastien Roger; Pierre Besson; Stephan Chevalier
Journal:  Biochim Biophys Acta       Date:  2013-07-30

3.  Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.

Authors:  Lie Yang; Hong Zhang; Zong-Guang Zhou; Hui Yan; G Adell; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

4.  Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.

Authors:  Pengfei He; Michael G Borland; Bokai Zhu; Arun K Sharma; Shantu Amin; Karam El-Bayoumy; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2008-10-02       Impact factor: 4.221

5.  Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.

Authors:  Thaddeus T Schug; Daniel C Berry; Illia A Toshkov; Le Cheng; Alexander Yu Nikitin; Noa Noy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-21       Impact factor: 11.205

6.  Transcriptional network governing the angiogenic switch in human pancreatic cancer.

Authors:  Amir Abdollahi; Christian Schwager; Jörg Kleeff; Irene Esposito; Sophie Domhan; Peter Peschke; Kai Hauser; Philip Hahnfeldt; Lynn Hlatky; Jürgen Debus; Jeffrey M Peters; Helmut Friess; Judah Folkman; Peter E Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

7.  Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

Authors:  Xiangsheng Zuo; Zhanglong Peng; Micheline J Moussalli; Jeffrey S Morris; Russell R Broaddus; Susan M Fischer; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

8.  Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.

Authors:  Yasuhiro Ito; Yuichi Oike; Kunio Yasunaga; Koichi Hamada; Keishi Miyata; Shun-Ichiro Matsumoto; Sumio Sugano; Hidenobu Tanihara; Yasuhiko Masuho; Toshio Suda
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

9.  Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4.

Authors:  Hongfei Ge; Guoqing Yang; Xinxin Yu; Tiffany Pourbahrami; Cai Li
Journal:  J Lipid Res       Date:  2004-08-01       Impact factor: 5.922

10.  Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.

Authors:  Balázs Győrffy; Pawel Surowiak; Jan Budczies; András Lánczky
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more
  34 in total

1.  Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.

Authors:  Adeline Péchery; Sylvie Fauconnet; Hugues Bittard; Isabelle Lascombe
Journal:  Tumour Biol       Date:  2016-09-16

2.  PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.

Authors:  Xiangsheng Zuo; Yasunori Deguchi; Weiguo Xu; Yi Liu; Haiyan S Li; Daoyan Wei; Rui Tian; Weidong Chen; Min Xu; Yaying Yang; Shen Gao; Jonathan C Jaoude; Fuyao Liu; Sarah P Chrieki; Micheline J Moussalli; Mihai Gagea; Manu M Sebastian; Xiaofeng Zheng; Dongfeng Tan; Russell Broaddus; Jing Wang; Nadim J Ajami; Alton G Swennes; Stephanie S Watowich; Imad Shureiqi
Journal:  Gastroenterology       Date:  2019-03-15       Impact factor: 22.682

Review 3.  Lipid metabolism and lipophagy in cancer.

Authors:  Meenu Maan; Jeffrey M Peters; Mainak Dutta; Andrew D Patterson
Journal:  Biochem Biophys Res Commun       Date:  2018-02-10       Impact factor: 3.575

4.  Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.

Authors:  Pei-Li Yao; Liping Chen; Tomasz P Dobrzański; Bokai Zhu; Boo-Hyon Kang; Rolf Müller; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2017-01-13       Impact factor: 4.784

5.  Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.

Authors:  Pei-Li Yao; Jose L Morales; Frank J Gonzalez; Jeffrey M Peters
Journal:  Immunology       Date:  2017-01-24       Impact factor: 7.397

Review 6.  PPARs and nonalcoholic fatty liver disease.

Authors:  Kim H H Liss; Brian N Finck
Journal:  Biochimie       Date:  2016-12-02       Impact factor: 4.079

Review 7.  Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.

Authors:  Jeffrey M Peters; Dae J Kim; Moses T Bility; Michael G Borland; Bokai Zhu; Frank J Gonzalez
Journal:  Mol Carcinog       Date:  2019-05-06       Impact factor: 4.784

8.  Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.

Authors:  Michael G Borland; Ellen M Kehres; Christina Lee; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2018-05-03       Impact factor: 4.221

Review 9.  Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-07-02

10.  Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.

Authors:  Michael G Borland; Pei-Li Yao; Ellen M Kehres; Christina Lee; Amanda M Pritzlaff; Elizabeth Ola; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Boo-Hyon Kang; Gavin P Robertson; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2017-10-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.